These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36047789)

  • 1. Angiotensin-receptor blocker losartan alleviates atrial fibrillation in rats by downregulating frizzled 8 and inhibiting the activation of WNT-5A pathway.
    Feng R; Wan J; He Y; Gong H; Xu Z; Feng J
    Clin Exp Pharmacol Physiol; 2023 Jan; 50(1):19-27. PubMed ID: 36047789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of miR-27b-3p Targeting Wnt3a Regulates the Signaling Pathway of Wnt/
    Lv X; Li J; Hu Y; Wang S; Yang C; Li C; Zhong G
    Oxid Med Cell Longev; 2019; 2019():5703764. PubMed ID: 31178968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β-induced profibrotic signaling is regulated in part by the WNT receptor Frizzled-8.
    Spanjer AI; Baarsma HA; Oostenbrink LM; Jansen SR; Kuipers CC; Lindner M; Postma DS; Meurs H; Heijink IH; Gosens R; Königshoff M
    FASEB J; 2016 May; 30(5):1823-35. PubMed ID: 26849959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-17A contributes to the development of post-operative atrial fibrillation by regulating inflammation and fibrosis in rats with sterile pericarditis.
    Fu XX; Zhao N; Dong Q; Du LL; Chen XJ; Wu QF; Cheng X; Du YM; Liao YH
    Int J Mol Med; 2015 Jul; 36(1):83-92. PubMed ID: 25955429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7.
    He X; Gao X; Peng L; Wang S; Zhu Y; Ma H; Lin J; Duan DD
    Circ Res; 2011 Jan; 108(2):164-75. PubMed ID: 21127293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of angiotensin receptor blocker (losartan) on decreasing fibrotic process of corpora cavernosa in priapism model of wistar rats.
    Siregar S; Rulianov R; Ksatriapraja RA; Stefanus D
    F1000Res; 2022; 11():831. PubMed ID: 38046538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR‑101a‑3p overexpression prevents acetylcholine‑CaCl
    Zhu J; Zhu N; Xu J
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34435649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quercetin improves atrial fibrillation through inhibiting TGF-β/Smads pathway via promoting MiR-135b expression.
    Wang H; Jiang W; Hu Y; Wan Z; Bai H; Yang Q; Zheng Q
    Phytomedicine; 2021 Dec; 93():153774. PubMed ID: 34656066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermedin 1-53 Ameliorates Atrial Fibrosis and Reduces Inducibility of Atrial Fibrillation via TGF-β1/pSmad3 and Nox4 Pathway in a Rat Model of Heart Failure.
    Ma S; Yan F; Hou Y
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pinocembrin alleviates the susceptibility to atrial fibrillation in isoproterenol-induced rats.
    Liu Z; Chen X; Ye T; Wan W; Yu Y; Zhang C; Yang B
    Biochem Biophys Res Commun; 2022 Dec; 636(Pt 1):33-40. PubMed ID: 36332480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of fibromodulin attenuates inflammatory signaling and atrial fibrosis in spontaneously hypertensive rats with atrial fibrillation via inhibiting TLR4/NLRP3 signaling pathway.
    Liang Y; Zhou Y; Wang J; He Y
    Immun Inflamm Dis; 2023 Oct; 11(10):e1003. PubMed ID: 37904680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model.
    Kim MY; Baik SK; Park DH; Jang YO; Suk KT; Yea CJ; Lee IY; Kim JW; Kim HS; Kwon SO; Cho MY; Ko SB; Chang SJ; Um SH; Han KH
    J Gastroenterol; 2008; 43(11):889-96. PubMed ID: 19012043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of TGF-β1/α-SMA/Col I Profibrotic Pathway in Fibroblasts by Galectin-3 Contributes to Atrial Fibrosis in Experimental Models and Patients.
    Shen H; Wang J; Min J; Xi W; Gao Y; Yin L; Yu Y; Liu K; Xiao J; Zhang YF; Wang ZN
    Cell Physiol Biochem; 2018; 47(2):851-863. PubMed ID: 29807358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTRP9 Ameliorates Atrial Inflammation, Fibrosis, and Vulnerability to Atrial Fibrillation in Post-Myocardial Infarction Rats.
    Liu M; Li W; Wang H; Yin L; Ye B; Tang Y; Huang C
    J Am Heart Assoc; 2019 Nov; 8(21):e013133. PubMed ID: 31623508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA MIAT/miR-133a-3p axis regulates atrial fibrillation and atrial fibrillation-induced myocardial fibrosis.
    Yao L; Zhou B; You L; Hu H; Xie R
    Mol Biol Rep; 2020 Apr; 47(4):2605-2617. PubMed ID: 32130618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased α-Actinin-2 Expression in the Atrial Myocardium of Patients with Atrial Fibrillation Related to Rheumatic Heart Disease.
    Zhang L; Zhang N; Tang X; Liu F; Luo S; Xiao H
    Cardiology; 2016; 135(3):151-159. PubMed ID: 27344599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tea Polyphenols Regulate Renin-angiotensin-aldosterone System and Transforming Growth Factor-β1/Smads Signaling Pathway in Heart Failure Rats].
    Wan LF; Yuan ZJ; Chen H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Jun; 44(3):384-391. PubMed ID: 35791933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigallocatechin-3-Gallate Inhibits Atrial Fibrosis and Reduces the Occurrence and Maintenance of Atrial Fibrillation and its Possible Mechanisms.
    Li T; Tong Q; Wang Z; Yang Z; Sun Y; Cai J; Xu Q; Lu Y; Liu X; Lin K; Qian Y
    Cardiovasc Drugs Ther; 2024 Oct; 38(5):895-916. PubMed ID: 37000367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of Transient Receptor Potential Canonical Type 3 Channel via AT1R/TGF-
    He R; Zhang J; Luo D; Yu Y; Chen T; Yang Y; Yu F; Li M
    Oxid Med Cell Longev; 2019; 2019():4025496. PubMed ID: 31871548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis.
    Namisaki T; Kaji K; Shimozato N; Kaya D; Ozutsumi T; Tsuji Y; Fujinaga Y; Kitagawa K; Furukawa M; Sato S; Sawada Y; Nishimura N; Takaya H; Okura Y; Seki K; Kawaratani H; Moriya K; Noguchi R; Asada K; Akahane T; Mitoro A; Yoshiji H
    Indian J Gastroenterol; 2022 Apr; 41(2):169-180. PubMed ID: 35279807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.